Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,170.50
+1.75 (0.08%)
At close: Mar 27, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 612.52 billion as of March 27, 2026. Its market cap has increased by 55.41% in one year.
Market Cap
612.52B
Enterprise Value
597.85B
Revenue
165.10B
Ranking
n/a
PE Ratio
57.51
Stock Price
2,170.50
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 612.52B, an increase of 53,194.63%. That is a compound annual growth rate of 28.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 612.52B | 6.65% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.44T |
| Dr. Reddy's Laboratories | 1.08T |
| Lupin | 1.07T |
| Abbott India | 560.93B |
| GlaxoSmithKline Pharmaceuticals | 382.72B |
| J. B. Chemicals & Pharmaceuticals | 330.39B |
| AstraZeneca Pharma India | 198.65B |
| Granules India | 155.80B |